Virus-like particles (VLPs) are nanoscale particles, approximately 100–300 nm in diameter, formed by self-assembly of viral capsid proteins, which lack viral genetic material, cannot replicate ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics. As the old philosophical question goes, ...
In the Virus-Like Particle Translational Oncology Laboratory, Qizhi Cathy Yao, M.D., Ph.D. is developing non-infectious HIV virus-like particles (VLPs) as candidate HIV mucosal vaccines for both ...
Icosavax has drawn up clinical trial plans for its new type of vaccine in a strategy to commence tests of multiple programs, including a Covid-19 candidate. But really, the startup is following a path ...
CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address ...
A viral particle with an unprecedentedly long 'tail' has been caught infecting dinoflagellate plankton in the Pacific Ocean.
Morphological features guiding the preliminary identification of newly isolated viruses (negative staining, TEM). (A) The large ovoid particle (1000 nm in length) of Pandoravirus yedoma (strain Y2) ...
Virus particles come from people, like you and me, when we are ill, even before we are symptomatic. While the necessity for masks for this pandemic may be ending, barrier face coverings (BFC) may, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback